請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28650
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 許翠瑛 | |
dc.contributor.author | Ting-Yau Lee | en |
dc.contributor.author | 李廷曜 | zh_TW |
dc.date.accessioned | 2021-06-13T00:15:42Z | - |
dc.date.available | 2012-08-08 | |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-27 | |
dc.identifier.citation | Adams, A. & Lindahl, T. (1975). Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci U S A 72, 1477-81.
Adamson, A. L. & Kenney, S. C. (1998). Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Virology 251, 187-97. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Seguin, C. & et al. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-11. Bjerke, S. L. & Roller, R. J. (2006). Roles for herpes simplex virus type 1 UL34 and US3 proteins in disrupting the nuclear lamina during herpes simplex virus type 1 egress. Virology 347, 261-76. Burke, A. P., Yen, T. S., Shekitka, K. M. & Sobin, L. H. (1990). Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 3, 377-80. Calderwood, M. A., Venkatesan, K., Xing, L., Chase, M. R., Vazquez, A., Holthaus, A. M., Ewence, A. E., Li, N., Hirozane-Kishikawa, T., Hill, D. E., Vidal, M., Kieff, E. & Johannsen, E. (2007). Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci U S A 104, 7606-11. Chang, Y., Tung, C. H., Huang, Y. T., Lu, J., Chen, J. Y. & Tsai, C. H. (1999). Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 73, 8857-66. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J. & Sergeant, A. (1986). Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. Embo J 5, 3243-9. Cho, M. S., Milman, G. & Hayward, S. D. (1985). A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. J Virol 56, 860-6. Clough, W. (1979). Deoxyribonuclease activity found in Epstein--Barr virus producing lymphoblastoid cells. Biochemistry 18, 4517-21. Countryman, J., Jenson, H., Seibl, R., Wolf, H. & Miller, G. (1987). Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol 61, 3672-9. Countryman, J. & Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A 82, 4085-9. Cox, M. A., Leahy, J. & Hardwick, J. M. (1990). An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol 64, 313-21. Dolyniuk, M., Pritchett, R. & Kieff, E. (1976). Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J Virol 17, 935-49. Epstein, M. A., Achong, B. G. & Barr, Y. M. (1964). Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 15, 702-3. Farina, A., Feederle, R., Raffa, S., Gonnella, R., Santarelli, R., Frati, L., Angeloni, A., Torrisi, M. R., Faggioni, A. & Delecluse, H. J. (2005). BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. J Virol 79, 3703-12. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. & Delecluse, H. J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. Embo J 19, 3080-9. Frame, M. C., Purves, F. C., McGeoch, D. J., Marsden, H. S. & Leader, D. P. (1987). Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J Gen Virol 68 ( Pt 10), 2699-704. Gershburg, E., Raffa, S., Torrisi, M. R. & Pagano, J. S. (2007). Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J Virol 81, 5407-12. Given, D. & Kieff, E. (1979). DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. J Virol 31, 315-24. Given, D., Yee, D., Griem, K. & Kieff, E. (1979). DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA. J Virol 30, 852-62. Gonnella, R., Farina, A., Santarelli, R., Raffa, S., Feederle, R., Bei, R., Granato, M., Modesti, A., Frati, L., Delecluse, H. J., Torrisi, M. R., Angeloni, A. & Faggioni, A. (2005). Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. J Virol 79, 3713-27. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36, 59-74. Grinstein, S., Preciado, M. V., Gattuso, P., Chabay, P. A., Warren, W. H., De Matteo, E. & Gould, V. E. (2002). Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 62, 4876-8. Gruffat, H., Duran, N., Buisson, M., Wild, F., Buckland, R. & Sergeant, A. (1992). Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter. J Virol 66, 46-52. Hammerschmidt, W. & Sugden, B. (1988). Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55, 427-33. Hampar, B., Derge, J. G., Martos, L. M. & Walker, J. L. (1971). Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Proc Natl Acad Sci U S A 68, 3185-9. Hatfull, G., Bankier, A. T., Barrell, B. G. & Farrell, P. J. (1988). Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164, 334-40. Henle, G., Henle, W. & Diehl, V. (1968). Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A 59, 94-101. Holley-Guthrie, E. A., Quinlivan, E. B., Mar, E. C. & Kenney, S. (1990). The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J Virol 64, 3753-9. Hsu, T. Y., Chang, Y., Wang, P. W., Liu, M. Y., Chen, M. R., Chen, J. Y. & Tsai, C. H. (2005). Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal. J Gen Virol 86, 317-22. Huang, J., Chen, H., Hutt-Fletcher, L., Ambinder, R. F. & Hayward, S. D. (2003). Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol 77, 13267-74. Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D. & Kieff, E. (2004). Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A 101, 16286-91. Jones, J. F., Shurin, S., Abramowsky, C., Tubbs, R. R., Sciotto, C. G., Wahl, R., Sands, J., Gottman, D., Katz, B. Z. & Sklar, J. (1988). T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318, 733-41. Kallin, B., Sternas, L., Saemundssen, A. K., Luka, J., Jornvall, H., Eriksson, B., Tao, P. Z., Nilsson, M. T. & Klein, G. (1985). Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells. J Virol 54, 561-8. Kato, A., Yamamoto, M., Ohno, T., Tanaka, M., Sata, T., Nishiyama, Y. & Kawaguchi, Y. (2006). Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. J Virol 80, 1476-86. Kenney, S., Holley-Guthrie, E., Mar, E. C. & Smith, M. (1989). The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J Virol 63, 3878-83. Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T. & et al. (1988). Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333, 455-7. Klein, G., Clifford, P., Klein, E. & Stjernsward, J. (1966). Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A 55, 1628-35. Klupp, B. G., Granzow, H., Keil, G. M. & Mettenleiter, T. C. (2006). The capsid-associated UL25 protein of the alphaherpesvirus pseudorabies virus is nonessential for cleavage and encapsidation of genomic DNA but is required for nuclear egress of capsids. J Virol 80, 6235-46. Lake, C. M. & Hutt-Fletcher, L. M. (2004). The Epstein-Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization. Virology 320, 99-106. Lee, C. P., Chen, J. Y., Wang, J. T., Kimura, K., Takemoto, A., Lu, C. C. & Chen, M. R. (2007). Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II. J Virol 81, 5166-80. Lin, C. T., Chan, W. Y., Chen, W., Huang, H. M., Wu, H. C., Hsu, M. M., Chuang, S. M. & Wang, C. C. (1993). Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 68, 716-27. Lindahl, T., Adams, A., Andersson-Anvret, M. & Falk, L. (1978). Integration of Epstein-Barr virus DNA. IARC Sci Publ, 113-23. Littler, E. & Arrand, J. R. (1988). Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems. J Virol 62, 3892-5. Liu, C., Sista, N. D. & Pagano, J. S. (1996). Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J Virol 70, 2545-55. Lu, C. C., Jeng, Y. Y., Tsai, C. H., Liu, M. Y., Yeh, S. W., Hsu, T. Y. & Chen, M. R. (2006). Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 345, 358-72. Manet, E., Rigolet, A., Gruffat, H., Giot, J. F. & Sergeant, A. (1991). Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. Nucleic Acids Res 19, 2661-7. Martin-Serrano, J., Zang, T. & Bieniasz, P. D. (2001). HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 7, 1313-9. McNab, A. R., Desai, P., Person, S., Roof, L. L., Thomsen, D. R., Newcomb, W. W., Brown, J. C. & Homa, F. L. (1998). The product of the herpes simplex virus type 1 UL25 gene is required for encapsidation but not for cleavage of replicated viral DNA. J Virol 72, 1060-70. Mettenleiter, T. C. (2004). Budding events in herpesvirus morphogenesis. Virus Res 106, 167-80. Mettenleiter, T. C., Klupp, B. G. & Granzow, H. (2006). Herpesvirus assembly: a tale of two membranes. Curr Opin Microbiol 9, 423-9. Miller, R. L., Glaser, R. & Rapp, F. (1977). Studies of an Epstein-Barr virus-induced DNA polymerase. Virology 76, 494-502. Ogasawara, M., Suzutani, T., Yoshida, I. & Azuma, M. (2001). Role of the UL25 gene product in packaging DNA into the herpes simplex virus capsid: location of UL25 product in the capsid and demonstration that it binds DNA. J Virol 75, 1427-36. Old, L. J., Boyse, E. A., Oettgen, H. F., Harven, E. D., Geering, G., Williamson, B. & Clifford, P. (1966). Precipitating Antibody in Human Serum to an Antigen Present in Cultured Burkitt's Lymphoma Cells. Proc Natl Acad Sci U S A 56, 1699-1704. Park, R. & Baines, J. D. (2006). Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B. J Virol 80, 494-504. Quinlivan, E. B., Holley-Guthrie, E. A., Norris, M., Gutsch, D., Bachenheimer, S. L. & Kenney, S. C. (1993). Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res 21, 1999-2007. Ragoczy, T., Heston, L. & Miller, G. (1998). The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72, 7978-84. Rickinson, A. B. & Kieff, E. (1996). Epstein-Barr virus. In Field's Virology, 3rd edn, pp. 2343-2396. Sixbey, J. W., Vesterinen, E. H., Nedrud, J. G., Raab-Traub, N., Walton, L. A. & Pagano, J. S. (1983). Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306, 480-3. Takada, K., Shimizu, N., Sakuma, S. & Ono, Y. (1986). trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57, 1016-22. Tovey, M. G., Lenoir, G. & Begon-Lours, J. (1978). Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276, 270-2. Tsai, C. H., Liu, M. T., Chen, M. R., Lu, J., Yang, H. L., Chen, J. Y. & Yang, C. S. (1997). Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus. J Biomed Sci 4, 69-77. Tsai, C. H., Williams, M. V. & Glaser, R. (1991). Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function. J Virol Methods 33, 47-52. Tsai, W. S., Chang, M. H., Chen, J. Y., Lee, C. Y. & Liu, Y. G. (1989). Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 30, 81-6. VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J. & Carter, C. A. (2001). Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A 98, 7724-9. Walling, D. M., Edmiston, S. N., Sixbey, J. W., Abdel-Hamid, M., Resnick, L. & Raab-Traub, N. (1992). Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci U S A 89, 6560-4. Wang, J. T., Yang, P. W., Lee, C. P., Han, C. H., Tsai, C. H. & Chen, M. R. (2005). Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J Gen Virol 86, 3215-25. Weiss, L. M., Strickler, J. G., Warnke, R. A., Purtilo, D. T. & Sklar, J. (1987). Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129, 86-91. Yates, J., Warren, N., Reisman, D. & Sugden, B. (1984). A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 81, 3806-10. Yates, J. L., Warren, N. & Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-5. Zalani, S., Holley-Guthrie, E. & Kenney, S. (1996). Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci U S A 93, 9194-9. zur Hausen, H., O'Neill, F. J., Freese, U. K. & Hecker, E. (1978). Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272, 373-5. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28650 | - |
dc.description.abstract | EB病毒的BVRF1蛋白質被推測為是一個可能與外殼連接的被膜蛋白(capsid associated tegument protein)。在BVRF1的同源蛋白UL25的研究中,發現UL25蛋白質在疱疹病毒科的第一型單純疱疹病毒(herpes simplex virus 1, HSV-1)的入殼過程(encapsidation)中是必須的,且主要參與在穩定病毒的DNA-蛋白質殼(nucleocapsid)構造的功能,而不會直接參與病毒DNA截切的過程;然而在與HSV-1屬同一亞科的偽狂犬病病毒(PrV)的UL25對於DNA-蛋白質殼離開核膜(nuclear egress)的過程是重要的,但並不會穩定DNA-蛋白質殼的構造。目前尚無任何研究探討EB病毒BVRF1蛋白質在病毒顆粒形成過程中的角色。由yeast two-hybrid研究中發現BVRF1蛋白質與BFRF1 、BFLF2及BGLF4蛋白質有交互作用。BFRF1 與BFLF2蛋白質是病毒DNA-蛋白質殼通過宿主細胞核膜重要的蛋白質;而BGLF4蛋白質是EB病毒目前已知唯一的蛋白質激酶,且最近的報導顯示BGLF4蛋白質也與DNA-蛋白質殼出核有關,此結果暗示著BVRF1蛋白質可能在病毒顆粒的形成過程中扮演重要的角色。本實驗的目的在瞭解BVRF1蛋白質的基本特性及其可能的生物性功能。首先觀察當NA細胞處理TPA/sodium butyrate 使細胞內的EB病毒進入溶裂期24小時之後,利用BVRF1多株抗體可偵測到BVRF1蛋白質的表現;進一步利用免疫螢光染色分析發現BVRF1蛋白質主要表現在細胞質,然而經由細胞質核分離 (subcellular fractionation)分析,顯示BVRF1蛋白質在細胞內質核的分佈約各佔一半,同時藉由螢光酵素-報導基因檢測發現BVRF1啟動子主要是受到Rta蛋白質所調控。此外,利用共同免疫沉澱法也證明HA-BVRF1與BGLF4蛋白質在細胞內有交互關係;而內源性BFRF1與BGLF4及HA-BVRF1這三個蛋白質亦有交互關係;當在HeLa細胞共同表現BGLF4與HA-BVRF1蛋白質時,在電泳分析下發現HA-BVRF1的分子量有增加,暗示HA-BVRF1可能為BGLF4蛋白激酶之受質。 | zh_TW |
dc.description.abstract | Epstein-Barr virus (EBV) BVRF1 was recognized as a capsid-associated tegument protein through the sequence homology with the Herpes simplex virus type 1 (HSV-1) UL25 gene. It was demonstrated previously that UL25 protein is required for encapsidation but not for cleavage of replicated viral DNA. In addition, the UL25 of pseudorabies virus (PrV) which also belongs to α-herpersvirus family also was shown to play an important role on nuclear export of viral nucleocapsides. The observation from yeast two-hybrid assay indicated that BVRF1 could interact with BGLF4 (protein kinase), BFRF1 and BFLF2. The BFRF1 and BFLF2 proteins were identified to be necessary for efficient viral envelopment at the nuclear membrane. Recent study also indicated that BGLF4 might be involved in the egress of viral nucleocapsids. Taken together with the analogy to the crucial roles of other viral UL25 and findings from yeast two-hybrid assay, we wondered whether BVRF1 might play an important role in the encapsidation of EBV. Despite that, the expression and biological function of BVRF1 have not been characterized. In this study, the expression kinetics and subcellular localization of BVRF1 products were detected in EBV-positive epithelial and B cells upon induction of lytic cycle by using BVRF1-specific mouse antibodies. BVRF1 is expressed in both the nuclei and cytoplasm of EBV-positive NA cells. The promoter activity of BVRF1 is regulated mainly by the immediate-early transcription activator Rta. Furthermore, HA-BVRF1 was shown to interact with endogenous BFRF1 and BGLF4 in EBV positive NA cells undergoing lytic viral replication by co-immunoprecipitation assays. In addition, the higher molecular mass of HA-BVRF1 was observed in SDS-PAGE analysis when BGLF4 was coexpressed in HeLa cells, suggesting HA-BVRF1 could be a potential subtract of BGLF4 protein kinase. Overall, we suggest the BVRF1 may participate in viral encapsidation and egress of viral nucleocapsids. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T00:15:42Z (GMT). No. of bitstreams: 1 ntu-96-R94445124-1.pdf: 1649654 bytes, checksum: 2870aee5cee5a21faeb4518c88e9711a (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 中文摘要………………………………………………………………………… i
英文摘要…………………………………………………………………………ii 目錄…………………………………………………………………………...…iii 序論………………………………………………………………………………1 實驗目的…………………………………………………………………………8 實驗材料…………………………………………………………………………9 實驗方法…………………………………………………………………….....17 結果……………………………………………………………………………..26 討論……………………………………………………………………………..30 圖表……………………………………………………………………………..34 參考文獻………………………………………………………………………..48 | |
dc.language.iso | zh-TW | |
dc.title | EB病毒BVRF1基因產物之分析 | zh_TW |
dc.title | Characterization of Epstein-Barr Virus BVRF1 Gene Product | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 蔡錦華,陳美如 | |
dc.subject.keyword | EB病毒,BVRF1,被膜蛋白,BFRF1,BFLF2,BGLF4, | zh_TW |
dc.subject.keyword | Epstein-Barr virus (EBV),BVRF1,tegument protein,BGLF4,BFRF1,BFLF2,nuclear egress,encapsidation, | en |
dc.relation.page | 54 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-27 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 1.61 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。